Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Antonio GrecoSimone FinocchiaroDominick J Angiolillo Davide Capodanno

Published in: Expert opinion on pharmacotherapy (2023)

This article reviews the evidence supporting recommendation on pharmacotherapy in patients presenting with a NSTE-ACS. Several randomized clinical trials are still ongoing and are expected to further inform scientific knowledge and clinical practice, with the final aim to improve the treatment of NSTE-ACS patients.

Keyphrases

acute coronary syndrome
end stage renal disease
newly diagnosed
ejection fraction
clinical practice
prognostic factors
healthcare
systematic review
smoking cessation
coronary artery disease
atrial fibrillation
patient reported
replacement therapy